Download video

GDF2025 – D2S20 – Closing Remarks

930 views

U.S. Food and Drug Administration

3 months ago

GDF2025 – D2S20 – Closing Remarks

GDF2025 – D2S20 – Closing Remarks

GDF2025 – D2S20 – Closing Remarks
5:22
GDF2025 – D2S20 – Closing Remarks
by U.S. Food and Drug Administration
Generic Drugs Forum (GDF) 2025 - Day 2
7:44:43
Generic Drugs Forum (GDF) 2025 - Day 2
by U.S. Food and Drug Administration
GDF2025 - D2S09 - Questions \& Panel Discussion - Session Two
26:27
GDF2025 - D2S09 - Questions \& Panel Discussion - Session Two
by U.S. Food and Drug Administration
GDF2025 – D1S02 - Office of Pharmaceutical Quality (OPQ) Keynote
11:02
GDF2025 – D1S02 - Office of Pharmaceutical Quality (OPQ) Keynote
by U.S. Food and Drug Administration
FDA Generic Drugs Forum 2025 - Pre-ANDA Meetings: Process and Best Practices
15:54
FDA Generic Drugs Forum 2025 - Pre-ANDA Meetings: Process and Best Practices
by The FDA Learning Cache
GDF2025 - D2S15 - Questions \& Panel Discussion - Session Three
18:31
GDF2025 - D2S15 - Questions \& Panel Discussion - Session Three
by U.S. Food and Drug Administration
Generic Drugs Forum (GDF) 2025 - Day 1
8:21:10
Generic Drugs Forum (GDF) 2025 - Day 1
by U.S. Food and Drug Administration
Impurities in Peptide Drug Substance, Dinesh Parmar, TIDES Asia 2025
28:39
Impurities in Peptide Drug Substance, Dinesh Parmar, TIDES Asia 2025
by PolyPeptide Group
Development and Delivery of Pharmaceutical Products (CMC) - MaRS Best Practices
1:07:46
Development and Delivery of Pharmaceutical Products (CMC) - MaRS Best Practices
by MaRS Startup Toolkit
GDF2025 - D2S04 - Questions \& Panel Discussion - Session One
17:30
GDF2025 - D2S04 - Questions \& Panel Discussion - Session One
by U.S. Food and Drug Administration
FDA Generic Drugs Forum 2025 - ANDA Common Major Deficiencies
15:59
FDA Generic Drugs Forum 2025 - ANDA Common Major Deficiencies
by The FDA Learning Cache
Pm 2025 2
6:39:02
Pm 2025 2
by Fang's Lab
FDA Generic Drugs Forum 2025 - Best Practices for Generic Drug Labeling
16:17
FDA Generic Drugs Forum 2025 - Best Practices for Generic Drug Labeling
by The FDA Learning Cache
GDF2025 – D1S01 - Office of Generic Drugs (OGD) Keynote
17:18
GDF2025 – D1S01 - Office of Generic Drugs (OGD) Keynote
by U.S. Food and Drug Administration
FDA Generic Drugs Forum 2025 - Minor Regulatory Errors with Major Consequences
17:04
FDA Generic Drugs Forum 2025 - Minor Regulatory Errors with Major Consequences
by The FDA Learning Cache
FDA Generic Drugs Forum 2025 - Day 2, Session 1 Q\&A
14:52
FDA Generic Drugs Forum 2025 - Day 2, Session 1 Q\&A
by The FDA Learning Cache
FDA Generic Drugs Forum 2025 - Project Managing Drug Assessors Under GDUFA III Regulations
17:32
FDA Generic Drugs Forum 2025 - Project Managing Drug Assessors Under GDUFA III Regulations
by The FDA Learning Cache
GDF2025 - D1S11 - Questions \& Panel Discussion - Session Two
14:38
GDF2025 - D1S11 - Questions \& Panel Discussion - Session Two
by U.S. Food and Drug Administration
GDF2025 - D1S15 - Questions \& Panel Discussion - Session Three
20:58
GDF2025 - D1S15 - Questions \& Panel Discussion - Session Three
by U.S. Food and Drug Administration
FDA Generic Drugs Forum 2025 - Day 2, Session 2 Q\&A
26:28
FDA Generic Drugs Forum 2025 - Day 2, Session 2 Q\&A
by The FDA Learning Cache
FDA GDF 2025 - Inactive Ingredients in Generic Drug Applications: Building a Global Understanding
15:51
FDA GDF 2025 - Inactive Ingredients in Generic Drug Applications: Building a Global Understanding
by The FDA Learning Cache
FDA Generic Drugs Forum 2025 - Day 2, Session 3 Q\&A
18:31
FDA Generic Drugs Forum 2025 - Day 2, Session 3 Q\&A
by The FDA Learning Cache